VAERS reports by lot

GSK Varicella/Shingles lot G47M2: VAERS reports

44 VAERS reports list lot G47M2 as a GSK Varicella/Shingles vaccine, received between 2018-05-01 and 2019-03-20. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
44
Reports
5%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)6434%
Injection-site / Local reaction2614%
Cardiac / Cardiovascular2312%
Dermatological (non-injection-site)2011%
Neurological169%
Gastrointestinal116%
Musculoskeletal105%
Allergic / Anaphylactic74%
Psychiatric / Neuropsychiatric63%
Respiratory21%
Thrombotic / Hematological11%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York7
Michigan4
Pennsylvania4
Alabama3
California2
Ohio2
Virginia2
Arizona2
Maryland2
Nebraska2
Florida1
Iowa1

Reports by month received

2018-0519
2018-0616
2018-072
2018-082
2018-093
2019-021
2019-031

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.